Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04LIR
|
|||
| Former ID |
DIB007235
|
|||
| Drug Name |
PD-159913
|
|||
| Synonyms |
PD-159913; CHEMBL60181; SCHEMBL8923309
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Terminated | [1] | |
| Company |
Pfizer Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H20NO5P
|
|||
| Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)C3=CC(=CC(=C3)CP(=O)(O)O)CC(C(=O)O)N
|
|||
| InChI |
1S/C20H20NO5P/c21-19(20(22)23)10-13-7-14(12-27(24,25)26)9-18(8-13)17-6-5-15-3-1-2-4-16(15)11-17/h1-9,11,19H,10,12,21H2,(H,22,23)(H2,24,25,26)/t19-/m0/s1
|
|||
| InChIKey |
GOPXMKDIVJBBQF-IBGZPJMESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008061) | |||
| REF 2 | WO patent application no. 2009,0164,86, Use of nmda receptor antagonists for treatment of urologic tumors. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.